IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S: Financial statements 2017
CVR: 16584037
Source: annual report 2017, Danish Business Authority
01/04/2016 – 31/03/2017
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S (CVR 16584037) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 6,643,668 and a net result of DKK 5,290,218 compared with DKK 6,107,917 the year before. That is a decrease of 21.7% compared with the year before. Equity in the 2017 report amounted to DKK 96,101,458. The solvency ratio was 99.8%.
- Gross Profit
- DKK 6,643,668
- Profit/Loss
- DKK 5,290,218
- Equity
- DKK 96,101,458
- Total Assets
- DKK 96,319,113
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 6.6M | 5.3M | 96.1M | - |
| 2016 | - | 8.5M | 6.1M | 90.8M | - |
| 2015 | - | 9M | 6M | 84.7M | - |
| 2014 | - | 13.4M | 9.2M | 78.7M | - |
| 2013 | - | 11.7M | 7.1M | 69.5M | - |
Official annual report
Keep an eye on IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of March 31, 2017, Régis Jacques Duval has joined the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 31, 2017, Carlos Patricio Lacalle Zando has stepped down as chairman of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
About IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S was a Danish company of the type Aktieselskab based in København S, founded in 1992. The company has been dissolved on 11 October 2019. The company was registered under the industry Engroshandel med kemiske produkter. The company was previously named NORDIC BIOSCIENCE DIAGNOSTICS A/S and OSTEOMETER BIOTECH A/S. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 877,018 and a net result of DKK 1,209,814 compared with DKK 5,073,540 the year before. Equity in the 2019 report amounted to DKK 102,384,800.